Infralimbic cortex activity is required for the expression but not the acquisition of conditioned safety.
Animals
Conditioning, Classical
/ drug effects
Extinction, Psychological
/ drug effects
Fear
/ drug effects
Female
GABA-A Receptor Agonists
/ pharmacology
Inhibition, Psychological
Male
Memory
/ drug effects
Muscimol
/ pharmacology
Prefrontal Cortex
/ drug effects
Rats
Rats, Sprague-Dawley
Reflex, Startle
/ drug effects
Anxiety disorder
Explicitly unpaired
Fear inhibition
Safety learning
Startle
Truly random control
Journal
Psychopharmacology
ISSN: 1432-2072
Titre abrégé: Psychopharmacology (Berl)
Pays: Germany
ID NLM: 7608025
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
06
12
2019
accepted:
13
04
2020
pubmed:
5
5
2020
medline:
21
10
2020
entrez:
5
5
2020
Statut:
ppublish
Résumé
The ability to discriminate between danger and safety is crucial for survival across species. Whereas danger signals predict the onset of a potentially threatening event, safety signals indicate the non-occurrence of an aversive event, thereby reducing fear and stress responses. While the neural basis of conditioned safety remains to be elucidated, fear extinction studies provide evidence that the infralimbic cortex (IL) modulates fear inhibition. In the current study, the IL was temporarily inactivated with local muscimol injections in male and female rats. The effect of IL inactivation on the acquisition and expression of conditioned safety was investigated utilizing the startle response. Temporary inactivation of the IL prior to conditioning did not affect the acquisition of conditioned safety, whereas IL inactivation during the expression test completely blocked the expression of conditioned safety in male and female rats. Inactivation of the neighboring prelimbic (PL) cortex during the expression test did not affect the expression of safety memory. Our findings suggest that the IL is a critical brain region for the expression of safety memory. Because patients suffering from anxiety disorders are often unable to make use of safety cues to inhibit fear, the present findings are of clinical relevance and could potentially contribute to therapy optimization of anxiety-related psychiatric disorders.
Identifiants
pubmed: 32363439
doi: 10.1007/s00213-020-05527-7
pii: 10.1007/s00213-020-05527-7
pmc: PMC7306044
doi:
Substances chimiques
GABA-A Receptor Agonists
0
Muscimol
2763-96-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2161-2172Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : SFB779/B13
Références
Neuropsychopharmacology. 2005 Jan;30(1):17-26
pubmed: 15257308
Behav Brain Res. 2016 Jan 1;296:249-253
pubmed: 26386302
Transl Psychiatry. 2020 Apr 24;10(1):120
pubmed: 32332716
Neuroscience. 2015 Jan 22;284:988-97
pubmed: 25451298
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3216-3221
pubmed: 28265059
J Neurosci. 2015 Feb 25;35(8):3607-15
pubmed: 25716859
J Comp Physiol Psychol. 1969 Apr;67(4):504-9
pubmed: 5787403
Behav Neurosci. 1995 Jun;109(3):379-87
pubmed: 7662148
Nat Neurosci. 2014 Jan;17(1):106-13
pubmed: 24241397
Learn Mem. 2006 Nov-Dec;13(6):728-33
pubmed: 17142302
Psychiatry Res. 2009 May 15;167(1-2):151-60
pubmed: 19345420
Behav Neurosci. 1997 Aug;111(4):712-26
pubmed: 9267649
Neurosci Biobehav Rev. 1999 May;23(5):743-60
pubmed: 10392663
Biol Psychiatry. 2011 Mar 15;69(6):556-63
pubmed: 21035787
Eur J Neurosci. 2013 Jan;37(2):259-68
pubmed: 23106416
Nat Protoc. 2010 May;5(5):954-62
pubmed: 20431541
Proc Natl Acad Sci U S A. 2010 May 18;107(20):9418-23
pubmed: 20439732
Psychol Rev. 1990 Jul;97(3):377-95
pubmed: 2200076
J Neurosci. 2013 Apr 24;33(17):7184-93
pubmed: 23616528
Behav Brain Res. 1993 Dec 20;58(1-2):175-98
pubmed: 8136044
Behav Brain Res. 2014 Oct 1;272:40-5
pubmed: 24995614
Behav Neurosci. 2010 Jun;124(3):391-7
pubmed: 20528083
Physiol Rev. 2010 Apr;90(2):419-63
pubmed: 20393190
J Abnorm Psychol. 1999 Feb;108(1):134-42
pubmed: 10066999
Neuropsychopharmacology. 2011 Jan;36(2):529-38
pubmed: 20962768
Sci Adv. 2015 Jul;1(6):
pubmed: 26504902
J Neurosci. 2008 Dec 10;28(50):13703-11
pubmed: 19074043
Neuropsychopharmacology. 2014 Feb;39(3):515-27
pubmed: 23963118
Neuropsychopharmacology. 2016 Apr;41(5):1261-73
pubmed: 26354044
Cell Rep. 2015 Mar 10;10(9):1435-1442
pubmed: 25753409
Ann N Y Acad Sci. 1997 Jun 21;821:1-9
pubmed: 9238189
J Neurosci Methods. 1999 Jan;86(2):129-43
pubmed: 10065982
Proc Natl Acad Sci U S A. 2019 Jun 25;116(26):13077-13086
pubmed: 31182594
Brain Res. 1998 Dec 7;813(2):274-82
pubmed: 9838162
Biol Psychiatry. 2006 Aug 15;60(4):376-82
pubmed: 16919525
Neurobiol Learn Mem. 2017 Nov;145:105-113
pubmed: 28893668
Depress Anxiety. 2015 Apr;32(4):239-53
pubmed: 25703487
Learn Mem. 2009 Aug 25;16(9):520-9
pubmed: 19706835
Depress Anxiety. 2010 Mar;27(3):244-51
pubmed: 20143428
Neuropsychopharmacology. 2018 Jul;43(8):1651-1659
pubmed: 29453443
Depress Anxiety. 2014 Apr;31(4):269-78
pubmed: 24634247
Learn Mem. 2010 Nov 01;17(11):591-9
pubmed: 21041382
Neuroscience. 2018 May 21;379:350-358
pubmed: 29604383
Cortex. 2013 Jul-Aug;49(7):1884-91
pubmed: 23020899
Neuron. 2005 Apr 21;46(2):309-20
pubmed: 15848808
Eur J Neurosci. 2007 Jan;25(2):559-66
pubmed: 17284198
Biol Psychiatry. 1995 Sep 15;38(6):378-85
pubmed: 8547457
Eur J Neurosci. 2006 Feb;23(3):758-64
pubmed: 16487156
Neuron. 2008 Oct 9;60(1):149-61
pubmed: 18940595
Eur J Neurosci. 1998 Dec;10(12):3876-84
pubmed: 9875364
J Exp Psychol Anim Behav Process. 1978 Apr;4(2):95-103
pubmed: 670892
Learn Mem. 2019 Jan 16;26(2):56-59
pubmed: 30651378
Brain Res. 2000 Oct 13;880(1-2):1-10
pubmed: 11032984
Nature. 2002 Nov 7;420(6911):70-4
pubmed: 12422216
Learn Mem. 2012 Oct 16;19(11):518-26
pubmed: 23073641
Psychiatr Ann. 2009 Jun 1;39(6):358-367
pubmed: 19779593
Neuropsychopharmacology. 2014 Sep;39(10):2405-13
pubmed: 24727732
Biol Psychiatry. 2018 Jul 15;84(2):129-137
pubmed: 29246436
Depress Anxiety. 2011 Dec 21;28(12):1058-66
pubmed: 21898707
Genes Brain Behav. 2020 Mar;19(3):e12621
pubmed: 31661603
Psychophysiology. 2020 Jan;57(1):e13356
pubmed: 30807663
J Neurosci. 2008 Jan 9;28(2):369-75
pubmed: 18184779
J Anxiety Disord. 2014 May;28(4):358-62
pubmed: 24786361
Psychol Rev. 1967 Jan;74(1):71-80
pubmed: 5341445
Behav Res Ther. 2009 Feb;47(2):111-8
pubmed: 19027893
PLoS One. 2012;7(5):e35853
pubmed: 22586453